Zaharaddeen Umar Na'ABba

Zaharaddeen Umar Na'ABba

Auto-generated profile, based on publicly available information

Zaharaddeen Umar Na'ABba

Department of Biological Sciences, Faculty of Science and Technology, Mewar University Chittorgarh. NH-79, Gangarar, Rajasthan 312901, India

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2020 in Acta Scientific Pharmaceutical Sciences
Verified
Journal Article
Closed access
ADAminu Ibrahim Danyaya
Aminu Ibrahim Danyaya
Abhishek Kumar VermaAbhishek Kumar Verma
Abhishek Kumar Verma
AKAvinash Kumar
Avinash Kumar
BSBinta Sunusi Shuaibu
Binta Sunusi Shuaibu
UHUmar Adamu Hamza
Umar Adamu Hamza
ADAbubakar Dabo Dalhat
Abubakar Dabo Dalhat

24 January 2022
Verified
Journal Article
Closed access
ZNZaharaddeen Umar Na’aBba
Zaharaddeen Umar Na’aBba
IGIliyasu Datti Gwarzo
Iliyasu Datti Gwarzo
PKPankaj Teli Kumar
Pankaj Teli Kumar
HSHassan Muhammad Sabo
Hassan Muhammad Sabo
MAMuhammad Abdullahi Auwal
Muhammad Abdullahi Auwal
In affluent countries, prostate cancer (PCa), one of the leading causes of male death, continues to be a serious medical burden. Androgen stimulates growth and advancement primarily through the androgen receptor. PCa is thought to include some molecular pathways in its growth and progression. In this work, several bioactive components of the neem plant (Azadirachta indica) were studied using the molecular docking analysis to identify and create novel medicines or inhibitors that can target androgen receptors for the treatment of prostate cancer. Azadirachta indica has been demonstrated to have therapeutic potential in the treatment of cancer. We investigated the molecular interactions of 30 bioactive chemicals in Azadirachta indica leaves against prostate cancer in this work. Androgen receptor protein is implicated in the genesis and progression of prostate cancer. A screening technique was used to perform molecular docking. PyMOL v 1.1r1 and Discovery studio 2020 were used to execute auto dock vina of the PyRx v 0.8 docking software and visualization, respectively. The SwissADME online software was used to assess the hit compounds’ physicochemical attributes. The selected ligands demonstrated good inhibitory action in docking tests with the target proteins. The binding affinities range from -6.0 to -8.5 (kcal/mol) in the docking results of the selected hits, which is greater than the typical medicines employed. Among the identified ligands, Etofenprox had the greatest binding score with the target protein, whereas 4-hydroxystyrene, 3-Methylbenzaldehyde, and Limonene had the lowest binding energy with the target protein.